Inhibition of insulin amyloid fibril formation by cyclodextrins

References

• Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 2014;21:221–4
   PubMed Web of Science ®Google Scholar
• Pickup JC. Amyloid and insulin infusion pumps. Diabet Med 1985;2:13–16
   PubMedGoogle Scholar
• Dische FE, Wernstedt C, Westermark GT, Westermark P, Pepys MB, Rennie JA, Gilbey SG, et al. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988;31:158–61
   PubMed Web of Science ®Google Scholar
• Swift B. Examination of insulin injection sites: an unexpected finding of localized amyloidosis. Diabet Med 2002;19:881–2
   PubMed Web of Science ®Google Scholar
• Lonsdale-Eccles AA, Gonda P, Gilbertson JA, Haworth AE. Localized cutaneous amyloid at an insulin injection site. Clin Exp Dermatol 2009;34:e1027–8
   PubMed Web of Science ®Google Scholar
• Nagase T, Katsura Y, Iwaki Y, Nemoto K, Sekine H, Miwa K, Oh-I T, et al. The insulin ball. Lancet 2009;373:184. doi: 10.1016/S0140-6736(09)60041-6
   PubMed Web of Science ®Google Scholar
• Yumlu S, Barany R, Eriksson M, Röcken C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum Pathol 2009;40:1655–60
   PubMed Web of Science ®Google Scholar
• Sie MP, van der Wiel HE, Smedts FM, de Boer AC. Human recombinant insulin and amyloidosis: an unexpected association. Neth J Med 2010;68:138–40
   PubMed Web of Science ®Google Scholar
• Kudo-Watanuki S, Kurihara E, Yamamoto K, Mukai K, Chen KR. Coexistence of insulin-derived amyloidosis and an overlying acanthosis nigricans-like lesion at the site of insulin injection. Clin Exp Dermatol 2013;38:25–9
   PubMed Web of Science ®Google Scholar
• Shikama Y, Kitazawa J, Yagihashi N, Uehara O, Murata Y, Yajima N, Wada R, et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med 2010;49:397–401
   PubMed Web of Science ®Google Scholar
• Sheldon B, Russell-Jones D, Wright J. Insulin analogues: an example of applied medical science. Diabetes Obes Metab 2009;11:5–19
   PubMed Web of Science ®Google Scholar
• Burke MJ, Rougvie MA. Cross-protein structures. I. Insulin fibrils. Biochemistry 1972;11:2435–9
   PubMed Web of Science ®Google Scholar
• Bouchard M, Zurdo J, Nettleton EJ, Dobson CM, Robinson CV. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci 2000;9:1960–7
   PubMed Web of Science ®Google Scholar
• Ivanova MI, Sievers SA, Sawaya MR, Wall JS, Eisenberg D. Molecular basis for insulin fibril assembly. Proc Natl Acad Sci USA 2009;106:18990–5
   PubMed Web of Science ®Google Scholar
• Nayak A, Dutta AK, Belfort G. Surface-enhanced nucleation of insulin amyloid fibrillation. Biochem Biophys Res Commun 2008;369:303–7
   PubMed Web of Science ®Google Scholar
• Crini G. Review: a history of cyclodextrins. Chem Rev 2014;114:10940–75
   PubMed Web of Science ®Google Scholar
• Gautam S, Karmakar S, Bose A, Chowdhury PK. β-Cyclodextrin and curcumin, a potent cocktail for disaggregating and/or inhibiting amyloids: a case study with α-synuclein. Biochemistry 2014;53:4081–3
   PubMed Web of Science ®Google Scholar
• Jono H, Anno T, Motoyama K, Misumi Y, Tasaki M, Oshima T, Mori Y, et al. Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis. Biochem J 2011;437:35–42
   PubMed Web of Science ®Google Scholar
• Uehata K, Anno T, Hayashida K, Motoyama K, Higashi T, Hirayama F, Ono N, et al. Effects of selected anionic β-cyclodextrins on persistence of blood glucose lowering by insulin glargine after subcutaneous injection to rats. J Drug Deliv 2011;2011: 195146. doi:10.1155/2011/195146
   PubMedGoogle Scholar
• Uehata K, Anno T, Hayashida K, Higashi T, Motoyama K, Hirayama F, Uekama K, et al. Peak-less hypoglycemic effect of insulin glargine by complexation with maltosyl-β-cyclodextrin. Int J Pharm 2012;422:33–9
   PubMed Web of Science ®Google Scholar
• Surmacz-Chwedoruk W1, Nieznańska H, Wójcik S, Dzwolak W. Cross-seeding of fibrils from two types of insulin induces new amyloid strains. Biochemistry 2012;51:9460–9
   PubMed Web of Science ®Google Scholar
• Tavornvipas S, Tajiri S, Hirayama F, Arima H, Uekama K. Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone. Pharm Res 2004;21:2369–76
   PubMed Web of Science ®Google Scholar
• Tavornvipas S, Hirayama F, Takeda S, Arima H, Uekama K. Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor. J Pharm Sci 2006;95:2722–9
   PubMed Web of Science ®Google Scholar